Tag: indication

The US FDA has approved AbbVie's Skyrizi (risankizumab) for use in children six years and older with moderate-to-severe plaque psoriasis or ...

Dementia and Alzheimer’s disease affect cognitive abilities, but in many cases, the condition isn’t discovered until there are obvious signs ...